HMOX1 and mature T-cell and NK-cell non-Hodgkin lymphoma: In-vitro and in-vivo studies found that targeting PTGDS could significantly inhibit the progression of PTCL through promoting ferroptosis process and iron metabolism, which was mediated by heme oxygenase 1 (HMOX1)-mediated heme degradation and ferritin autophagy.